AME Sublicense. MORPHOSYS hereby grants to ONCOMED a sublicense to the AME Patent Rights, to the extent necessary to practice any license granted by MORPHOSYS to ONCOMED herein; provided, however, that the sublicense to the AME Patent Rights granted under this Section 4.5(c) shall be subject to the limitations of the AME Sublicense Agreement and the “▇▇▇▇▇▇▇▇ Agreement” (as such term is defined in Section 1.10 of the AME Sublicense Agreement), redacted copies of which AME Sublicense Agreement and ▇▇▇▇▇▇▇▇ Agreement are attached hereto. ONCOMED acknowledges that MORPHOSYS has the obligation to notify AME in writing that ONCOMED has received a sublicense to the AME Patent Rights.
Appears in 2 contracts
Sources: Subscription and License Agreement (OncoMed Pharmaceuticals Inc), Subscription and License Agreement (OncoMed Pharmaceuticals Inc)